| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e2918a127af0c23f748b174fffbd608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14e34b9a96981756af380f46f3a78d5e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12 |
| filingDate |
2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c340126244e57d9798b77ce9b554325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f6b2ce4d1f8ddf9974c41191edc8d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17613c1aba9f7537e1569567947367cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd969f6a5eb74344d74a49d884a20171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a018dae55c4a8aadeee6c67bf2ec9e |
| publicationDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010266606-A1 |
| titleOfInvention |
Antibody therapy for highly pathogenic avian influenza virus |
| abstract |
The present invention relates to a monoclonal antibody against hemagglutinin of highly pathogenic avian influenza virus subtype H5 or functional fragment thereof, a hybridoma producing the monoclonal antibody, and a composition comprising the monoclonal antibody or functional fragment thereof. In addition, the present invention relates to a method for preventing or treating influenza virus infection by administering the composition to a subject, and an assay kit for influenza virus comprising the monoclonal antibody or functional fragment thereof. |
| priorityDate |
2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |